Search clinical trials for: tinzaparin

Total 217 results

University of Aarhus
Aarhus University Hospital; LEO Pharma

Completed

Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight? (IUGR)

Fetal Growth Retardation

Denmark
Tampere University Hospital

Recruiting

Efficacy, Safety and Pharmacokinetics of Tinzaparin During Slow Low Efficient Daily Dialysis in Intensive Care Patients (Tinza-SLEDD)

Acute Kidney Injury | Renal Replacement Therapy | Anticoagulants

Finland
Assistance Publique - Hôpitaux de Paris

Completed

ANTIcoagulation in Severe COVID-19 Patients (ANTICOVID)

Severe COVID-19 Pneumonia

France
Ribe County Hospital
LEO Pharma; Coloplast A/S

Terminated

MesoHep II: Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis

Inflammation | Peritoneal Dialysis | Nutrition

Denmark
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France

Terminated

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) (PROVE)

Venous Thromboembolism | Lung Neoplasm

France
University of Vermont
National Cancer Institute (NCI)

Unknown

Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery

Kidney Cancer

United States
University of Calgary
Canadian Institutes of Health Research (CIHR); LEO Pharma; Dupont Applied Biosciences

Completed

Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)

Thrombosis | Venous Thrombosis | Thromboembolism

Canada
King Saud University
King AbdulAziz City for Science and Technology

Unknown

Venous Thromboembolism Prophylaxis Post Cesarean Section (PROCS)

Bleeding | Venous Thromboembolism

Saudi Arabia
University Hospital of Patras

Recruiting

Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients (INTERACT)

Covid19 | Hospitalization

Greece
University of Southern California
Celgene Corporation

Terminated

Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer

Cancer | Venous Thromboembolism

United States
University of Calgary
Canadian Institutes of Health Research (CIHR); LEO Pharma; Dupont Applied Biosciences

Completed

Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin

Thrombosis | Venous Thrombosis | Thromboembolism

Canada
Ottawa Hospital Research Institute
LEO Pharma

Completed

A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery

Hemodialysis | Thromboembolism

Canada
Academisch Medisch Centrum - Universiteit van Amsterdam...
Netherlands Organisation for Scientific Research; Aspen Pharma; CHU of Saint... and other collaborators

Completed

Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy (Highlow)

Pulmonary Embolism | Deep Venous Thrombosis

Norway, Netherlands, Denmark, France, Belgium, Ireland, United States, Canada, Russian Federation, Spain
University Hospital, Linkoeping
Vastra Gotaland Region; Region Jönköping County; Region Västerbotten; Västervik...

Recruiting

Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer

Epithelial Ovarian Cancer

Sweden
Karolinska Institutet

Completed

Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients

Covid-19 | Bleeding | Thromboembolic Events

Sweden
Herlev Hospital

Recruiting

Study of Low Molecular Weight Heparins (DANHEP)

Venous Thromboembolism | Treatment | Prophylaxis | Anticoagulant

Denmark
Helsinki University Central Hospital

Recruiting

Pre- vs. Postoperative Thromboprophylaxis in Pancreatic Surgery (PREPOSTEROUS2)

Thrombosis | Bleeding | Surgery | Pancreas Cancer | Pancreas Neoplasm

Finland
Anemia Working Group Romania

Withdrawn

Effects of Tinzaparin on Cardio-vascular Outcomes and on Blood Lipids in Diabetic Patients on Chronic Hemodialysis

Diabetes Mellitus | Hemodialysis

Romania
Assistance Publique - Hôpitaux de Paris

Unknown

Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort (CORIMMUNO-COAG)

COVID19 Pneumonia

France
Karolinska Institutet

Completed

Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients

Covid19 | Thromboembolism

Sweden
Helsinki University Central Hospital
Academy of Finland; The Finnish Medical Association

Recruiting

Pre- vs Postoperative Thromboprophylaxis for Liver Resection (PREPOSTEROUS)

Bleeding | Surgery | Liver Cancer | Embolism, Pulmonary | Thrombosis, Deep Vein

Norway, Finland
Assistance Publique - Hôpitaux de Paris

Completed

Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT) (TILT)

Lung Cancer | Non Small Cell Lung Cancer

France
Sunnybrook Health Sciences Centre
LEO Pharma; Sunnybrook Research Institute

Terminated

Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome (TILE)

Deep Vein Thrombosis | Post Thrombotic Syndrome

Canada
Christine Ribic
McMaster University; LEO Pharma

Completed

Use of Tinzaparin for Anticoagulation in Hemodialysis (HEMO-TIN)

Kidney Failure, Chronic

Canada
Cardiff University
National Institute for Health Research, United Kingdom; Wales Cancer Trials...

Terminated

Anticoagulation Length in Cancer Associated Thrombosis (ALICAT)

Cancer | Thrombosis | Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolus

United Kingdom
Hospital Universitari de Bellvitge
LEO Pharma

Completed

Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis

Venous Thromboembolism

Spain
Complejo Hospitalario Xeral-Calde
LEO Pharma

Completed

Tinzaparin in the Treatment of the Acute Pulmonary Embolism

Acute Pulmonary Embolism

Spain
Duke University
Celgene Corporation

Completed

Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients

Primary Brain Tumor

United States
Aalborg University Hospital
Aalborg University

Completed

Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities

Deep Venous Thrombosis

Denmark
LEO Pharma

Completed

Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis

Deep Vein Thrombosis

Bulgaria, Croatia, Czechia, France, Germany, Poland, Romania, Serbia, Spain
Lawson Health Research Institute

Completed

A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients

Kidney Failure

Canada
Pfizer

Completed

Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice

Acute Coronary Syndrome

India
Centre Hospitalier Universitaire, Amiens

Recruiting

Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis (Aticks Live)

Inflammatory Response | Deep Vein Thrombosis

France
Ottawa Hospital Research Institute
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)...

Terminated

WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism (WAVe)

Obesity | Cancer | Venous Thromboembolism

Canada
Galician Research Group on Digestive Tumors
LEO Pharma

Recruiting

TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer (PROTINCOL)

Thromboembolism | Colorectal Cancer Metastatic

Spain
Ottawa Hospital Research Institute

Completed

Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal Cancer (PERIOP-01)

Adenocarcinoma of the Colon

Canada, France, Belgium
Pfizer

Completed

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Venous Thromboembolism

United States, Norway, Russian Federation, Slovenia, Spain
Groupe Hospitalier Pitie-Salpetriere
Assistance Publique Hopitaux De Marseille

Completed

Venous Thromboprophylaxis in Bariatric Surgery (OBSUD)

Obesity
Ontario Clinical Oncology Group (OCOG)
Pfizer

Completed

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Venous Thromboembolism | Brain Tumors

United States, Canada, Australia, Italy
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Dalteparin in Preventing DVT in Participants With Cancer

Soft Tissue Sarcoma | Lymphoma | Plasma Cell Myeloma | Bone Sarcoma | Femur Fracture | Metastatic Neoplasm | Pathologic Fracture

United States
University Medical Centre Ljubljana

Completed

Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis (REVETR)

Superficial Thrombophlebitis

Slovenia
Medical University of Vienna

Terminated

Thromboprophylaxis in Critically Ill Patients

Venous Thromboembolism

Austria
Ain Shams University

Unknown

Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment

Fetal Growth Restriction | Fetal Growth Abnormality

Egypt
Hospital Universitario Infanta Leonor

Completed

Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)

Covid19 | Thrombosis

Spain
Ottawa Hospital Research Institute
LEO Pharma

Completed

The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section

Deep Vein Thrombosis

Canada
Lawson Health Research Institute
Pfizer; Canadian Institutes of Health Research (CIHR)

Unknown

PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.

Stroke

India, Canada
Maisonneuve-Rosemont Hospital

Completed

Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses (STRIP)

Renal Insufficiency, Chronic | Deep Venous Thrombosis, Protection Against

Canada
M.D. Anderson Cancer Center
Eisai Inc.

Completed

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

Pancreatic Cancer | Venous Thromboembolism

United States
University of Calgary
LEO Pharma

Completed

Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing

Venous Thromboembolism

Canada
Lawson Health Research Institute
Pfizer

Completed

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

Embolism and Thrombosis

Canada

Search clinical trials for: tinzaparin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations